Exchange: NASDAQ·

CBAYCymabay Therapeutics Inc

$0.00
$0.00
(0.00%)
Today
Reported EarningsFeb 28
Mkt Cap$3.73B
Vol8.36M
News
all
press releases
News Placeholder
Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board
Alpha Cognition Inc. (Nasdaq: ACOG) (Alpha Cognition, or the Company), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding...
Business Wire
<
...
1
>
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.